Scientists Urge Clinical Trials to Determine Effects in Patients
CHARLOTTESVILLE, Va., Jan. 11, 2022 – New kidney research from the University of Virginia School of Medicine is raising
concerns that long-term use of drugs commonly prescribed to treat high-blood pressure and heart failure could be
contributing to kidney damage.
Patients should continue taking the medications, which include the well-known and widely used ACE inhibitors, the
researchers say. But the scientists are urging studies to better understand the drugs’ long-term effects.
“Our studies show that renin-producing cells are responsible for the damage. We are now focusing on understanding how
these cells, which are so important to defend us from drops in blood pressure and maintain our well-being, undergo such
transformation and induce kidney damage,” said Maria Luisa Sequeira Lopez MD, of UVA’s Department of Pediatrics and
Child Health Research Center. “What is needed is to identify what substances these cells make that lead to uncontrolled
vessel growth” in the kidney.Understanding Kidney Damage
Chronic high blood pressure affects a billion people around the world. The UVA researchers wanted to better understand
why severe forms of the condition are often accompanied by thickening of the arteries and small blood vessels in the
kidney, leading to organ damage.
They found that specialized kidney cells called renin cells play an important role. These cells normally produce renin,
a vital hormone that helps the body regulate blood pressure. But harmful changes in the renin cells can cause the cells
to invade the walls of the kidney’s blood vessels. The renin cells then trigger a buildup of another cell type, smooth
muscle cells, that cause the vessels to thicken and stiffen. The result: Blood can’t flow through the kidney as it
Further, the researchers found, long-term use of drugs that inhibit the renin-angiotensin system, such as ACE
inhibitors, or angiotensin receptor blockers, have a similar effect. These drugs are widely used for many purposes,
including treating high blood pressure, congestive heart failure and heart attacks, as well as to prevent major heart
problems. But long-term use of the drugs was associated with hardened kidney vessels in both lab mice and humans, the
The researchers note that the medications can be lifesaving for patients, so they stress the importance of continuing to
take them. But they say additional studies are needed to better understand the drugs’ long-term effects on the kidneys.
“It would be important to conduct prospective, randomized controlled studies to determine the extent of functional and
tissue damage in patients taking medications for blood pressure control,” said Ariel Gomez, MD, of UVA’s Department of
Pediatrics and Child Health Research Center. “It is imperative to find out what molecules these cells make so that we
can counteract them to prevent the damage while the hypertension is treated with the current drugs available today.”Findings Published
The researchers have published their findings in the scientific journal JCI Insight
. The article was selected as a cover story. The research team consisted of Hirofumi Watanabe, Alexandre G. Martini,
Evan A. Brown, Xiuyin Liang, Silvia Medrano, Shin Goto, Ichiei Narita, Lois J. Arend, Sequeira Lopez and Gomez.
The research was supported by the National Institutes of Health, grants P50 DK 096373, R01 DK 116718, R01 DK 116196, R01
DK 096373 and R01 HL 148044; and the Japan Society for the Promotion of Science Overseas Research Fellowships.
To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine
blog at http://makingofmedicine.virginia.edu